Pharmacovigilance–The next chapter

N Moore, D Berdaï, P Blin, C Droz - Therapies, 2019 - Elsevier
The discovery and quantification of adverse drug reactions has long relied on the careful
analysis of spontaneously reported cases. Causality assessment (imputation) was a …

Pharmacovigilance of sodium-glucose co-transporter-2 inhibitors: what a clinician should know on disproportionality analysis of spontaneous reporting systems

E Raschi, E Poluzzi, F Salvo, A Pariente… - Nutrition, Metabolism …, 2018 - Elsevier
Abstract Sodium-glucose co-transporter-2 inhibitors (SGLT2-Is) have consistently
demonstrated a clinically significant reduction of cardiovascular mortality. However, their …

Cardiovascular toxicity of tyrosine kinase inhibitors used in chronic myeloid leukemia: an analysis of the FDA adverse event reporting system database (FAERS)

S Cirmi, A El Abd, L Letinier, M Navarra, F Salvo - Cancers, 2020 - mdpi.com
Tyrosine kinase inhibitors (TKIs), the treatment of choice for chronic myeloid leukemia
(CML), can be associated to cardiovascular (CV) adverse events (AEs). A case/non-case …

Adverse drug reaction risks obtained from meta-analyses and pharmacovigilance disproportionality analyses are correlated in most cases

C Khouri, C Petit, M Tod, M Lepelley, B Revol… - Journal of Clinical …, 2021 - Elsevier
Objective We aimed at testing if a correlation between adverse drug reactions relative risks
estimated from meta-analyses and disproportionality analyses calculated from …

Good signal detection practices: evidence from IMI PROTECT

AFZ Wisniewski, A Bate, C Bousquet, A Brueckner… - Drug safety, 2016 - Springer
Over a period of 5 years, the Innovative Medicines Initiative PROTECT (
Pharmacoepidemiological Research on Outcomes of Therapeutics by a European …

Liver injury with novel oral anticoagulants: assessing post‐marketing reports in the US Food and Drug Administration adverse event reporting system

E Raschi, E Poluzzi, A Koci, F Salvo… - British journal of …, 2015 - Wiley Online Library
Aim We assessed the hepatic safety of novel oral anticoagulants (NOACs) analyzing the
publicly available US‐FDA adverse event reporting system (FAERS). Methods We extracted …

Impact of the COVID-19 pandemic on the spontaneous reporting and signal detection of adverse drug events

D Montes-Grajales, R Garcia-Serna, J Mestres - Scientific Reports, 2023 - nature.com
External factors severely affecting in a short period of time the spontaneous reporting of
adverse events (AEs) can significantly impact drug safety signal detection. Coronavirus …

Analysis of factors associated with hiccups based on the Japanese Adverse Drug Event Report database

R Hosoya, Y Uesawa, R Ishii-Nozawa, H Kagaya - PLoS One, 2017 - journals.plos.org
Hiccups are occasionally experienced by most individuals. Although hiccups are not life-
threatening, they may lead to a decline in quality of life. Previous studies showed that …

Drug-induced immune hemolytic anemia: detection of new signals and risk assessment in a nationwide cohort study

J Maquet, M Lafaurie, M Michel… - Blood …, 2024 - ashpublications.org
More than 130 drugs have been suspected to induce immune hemolytic anemia.
Comparative studies measuring the risk of drug-induced immune hemolytic anemia (DIIHA) …

Comprehensive study of the risk factors for medication-related osteonecrosis of the jaw based on the Japanese Adverse Drug Event Report Database

S Toriumi, A Kobayashi, Y Uesawa - Pharmaceuticals, 2020 - mdpi.com
Medication-related osteonecrosis of the jaw (MRONJ) is associated with many drugs,
including bisphosphonates (BPs). BPs are associated with atypical femoral fractures and …